mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.8 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |